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Summary: The high degree of constancy of enzyme catalytic activity in the plasma of a given individual is
regulated by a coihplex System of flux equilibria consisting of eight basic processes. Some of these processes
are of primarily theoretic importance. Enzymes from all tissues of the body, including the liver, are released
via a continuous physiological process into the interstitial space and get into the intravascular space by way
of lymphatic transport. The release of enzymes from tissues directly into the intravascular space is of secondary
importance äs is the exchange of enzyme molecules across capillary membranes from the intravascular to
the interstitial space and vice versa. In contrast, enzymes from circulating blood cells are transported directly
into the intravascular space. Enzymes are removed from the intravascular space at rates which vary greatly
between both enzymes and species. In a review of the literature, half-lives of diagnostically important enzymes
in plasma of man, dogs and rats were given and the striking differences in the results for a given enzyme
are discussed from a methodological point of view. In a mathematical analysis, data for lymphatic transport
of enzymes from dogs and rats (Lindena et al. (1986) this J. 24, 19 — 33) and of enzyme efflux from in vivo
ageing erythrocytes (Lindena et al. (1986) this J. 24, 49 — 59) into the plasma are related to the elimination
rate constaiits of enzymes from the plasma. The contribution of lymphatically transported enzymes to the
basal catalytic activity in plasma (Lindena & Trautschold (1986) this J. 24, 11 -18) amounts to 55-80% for
lactate dehydrogenase and rnalate dehydrogenase, 80 — 90% for adenylate kiriase and phosphohexose isomer-
ase, 90—95% for aspartate aminotransferase and aldolase and 99% for creatine kinase. A model of
Ca2+rmediated vesicular transport of enzymes out of ageing erythrocytes is proposed. The importance of
lymphatically transported enzymes to total plasma catalytic activity in dogs and rats argues for a similar
contribution of lymph transport in man.
Die Kinetik der Einstellung der kaialytischen Konzentration von Enzymen im Extrazellularraum bei Mensch,
Hund und Ratte
Versuch der Begründung einer quantitativen Diagnostischen Enzymologie, V.
Zusammenfassung: Die hohe intraindividuelle Konstanz von katalytischen Enzymaktivitäten im Plasma wird
durch ein komplexes System von Fließgewichten bestehend aus acht Grundprozessen aufrechterhalten, von
denen einige aber mehr von theoretischer Bedeutung sind. Aus allen Geweben des Körpers, einschließlich
der Leber, gelangen Enzyme — freigesetzt in einem kontinuierlichen physiologischen Vorgang — in den
interstitiellen Raum und von da über lymphatischen Transport in den Intravasalraum. Die Freisetzung von
Enzymen aus Geweben -direkt in den Intravasalraum als auch der Austausch von Enzymen vom Intravasal-
raum in den interstitiellen Raum über die Kapillarmembran und vice versa ist von untergeordneter Bedeutung.
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Enzyme aus zirkulierenden Blutzellen dagegen gelangen direkt in den Intravasalraum. Aus dein Intravasal-
raum werden Enzyme mit konstanten Raten eliminiert, die sich sowohl für die einzelnen Enzyme als auch
die Spezies deutlich unterscheiden. Eine Literaturübersicht der Halbwertszeiten von diagnostisch bedeutsamen
Enzymen im Plasma für Mensch, Hund und Ratte wurde erstellt und die deutlichen Unterschiede in den
Ergebnissen für das gleiche Enzym werden unter methodischen Gesichtspunkten diskutiert. Eine Berechnung
für Hund und Ratte stellt die Ergebnisse des lymphatischen Transports von Enzymen (Lindßpa et al. (1986)
this J. 24, 19-33) und des Enzymefflux von in vivo alternden Erythrocyten (Lindena et al. (1986) this J. 24,
49_59) in das Plasma der Eliminationskonstante von Enzymen aus dem Plasma gegenüber. Der Anteil des
lymphatischen Transports am Gesamtfluß zur Einstellung der basalen katalytischen Aktivität im Plasma
(Lindena & Trautschold (1986) this J. 24, 11-18) beträgt etwa 55-80% für Lactatdehydrogenase und
Malatdehydrogenase, 80-90% für Adenylatkinase und Phosphohexoseisomerase, 90—95% für
Aspartataminotransferase und Aldolase und 99% für Kreatinkinase. Es wird ein Modell vorgeschlagen,
das den Austritt von Enzymen aus alternden Erythrocyten über eine Ca^+-vermittelte Vesikulätion von
Erythrocytenmaterial erklärt. Die Bedeutung des lymphatischen Transports von Enzymen für die Einstellung
der basalen katalytischen Aktivität im Plasma bei Hund und Ratte läßt auf eine ähnliche Bedeutung des
Lymphtransportes für den Menschen schließen.
Introduction
The catalytic activity of enzymes in plasma is regu-
lated by a complex System of flux equilibria which
most likely consists of the processes shown diagram-
atically in figure 1.
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Fig. 1. Diagramatic Illustration of processes responsible for
the adjustment of enzyme catalytic activities in blood
plasma. For further details see text. Modified from
Friedel et al. (1).
1. The release of enzymes either from tissue cells into
the interstitial and/or intravascular space, charac-
terized by the rate constants K 7 and K 8, respec-
tively, or the release of enzymes from blood cells
into the intravascular space, characterized by the
rate constant K 6.
2. The exchange rate of enzyme molecules äcross
capillary membranes from the intravascular fo the
interstitial and from the interstitial to the intra-
vascular space, characterized by the rate constants
K l and K 2, which are measures of the capillary
permeability.
3. The elimination of enzyme molecules either from
the intravascular or the interstitial space, charac-
terized by the rate constants K 4 and K 5.
4. The transport of enzyme molecules from the inter-
stitial into the intravascular space via the lymph.
The constant K 3, characterizing this process, is a
measure of the lymphatic transport.
This rather confusing Systems of flux equilibria con-
sisting of eight basic processes can be reduced to
only five processes. This became evident from our
investigation on thoracic duct, hepatic and intestinal
lymph (2). We have shown that enzymes released
from the liver and other parenchymal tissues reach
the intravascular space primarily via the lymphatics.
Direct contributions of enzymes from the intracellu-
lar to the intravascular space (K 8), äs well äs ex-
changes äcross capillary membranes from the intersti-
tial to the intravascular space (K 2), are of secondary
importance. In addition, the elimination of enzymes
from the interstitial space (K 5) is negligible (3, 4).
Rate constants of significant importance are repre-
sented by solid lines, rate constants of minor impör-
tance by dashed lines. The ground work for quantita-
tive interspecies comparisons of enzyme kinetics in
the extracellular space has been laid in previous pub-
lications. Catalytic activity in plasma, the amount of
lymphatically transported catalytic activity, and the
efflux of catalytic activity from ageing erythrocytes
have already been estimated for a number of species
in these studies (2, 5, 6). Other fundamentale essential
in considering overall enzyme flux, such äs exchange
rates of enzymes from the intravascular to the inter-
stitial space, and plasma elimination rates, were ob-
tained from the liteterature and reyiewed. Our ahn
was to determine the precise sourees of plasma en-
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zyme catalytic activity and their degree of relative
importance. Under steady-state conditions, the cata-
lytic activity of diagnostically relevant enzymes has
been found to be highly constant for any given indivi-
dual in both man (7, 8) and rats (9). The basal
catalytic activity is the sum of contributing and elim-
inating rate constants, which are considered to be of
almost equal magnitude, and thereby result in a
steady-state.
Components which should contribute to the basal
plasma catalytic activity have been quantitied in sev-
eral animal species. These include lymphatic trans-
port (2) and the contribution of ageing erythrocytes
(6). The sum of these essential contributing rate con-
stants should be equal to the elimination rate con-
stant. With regard to man, data for lymphatic trans-
port of enzymes is not obtainable and complete quan-
titative calculations are therefore restricted to animals
such äs the dog and the rat.
Results of these animal studies can be related to the
Situation in human physiology.
Materials and Methods
Our calculations are based on the following assumptions:
1. Enzymes released from tissues in a constant physiological
process enter the blood only by lymphatic transport.
2. Thoracic duct lymph contains 60% of lymphatically trans-
ported enzymes. The right duct, the subclavian and the
cervical ducts account for the other 40%. These other ducts
have the same enzyme patteras äs the thoracic duct.
3. Enzymes are released from ageing erythrocytes in catalytic-
ally active form.
4. The transport rate of enzyme molecules across the capillary
membrane from the interstitial to the intravascular space
(K 2) is negligible.
5. The anaount of enzymes released from tissues (K 7) is repre-
sented by the lymphatic transport of enzymes (K 3).
6. The elimination of enzyme molecules from the interstitial
space (K 5) is negligible.
7. Flux of enzyme moleeules from the intravascular to the
interstitial space (K 1) is included in the lymphatic transport
of enzymes (K 3).
The validity of these assumptions will be discussed.
The following data were used for calculation:
Lymphatic transport of enzymes (K 3)
Table 2c from the II. communication of this series (2) listed
the lymphatic transport of enzymes in the thoracic duct. Data
are assumed to account for 60% of total body lymph enzyme
transport and are extrapolated to 100%. The values for con-
scious dogs and for anaesthetized rats during passive motion
were taken.
Release of enzymes from blood cells (K 6)
We have calculated the daily loss of -catalytic activity of total
body erythrocytes in man, dogs and rats in table l of the IV.
communication of this series (6).
Normal catalytic activity in plasma
Values for man, dogs and rats were taken from table l of the
I. communication (5).
Elimination constant (K 4)
Data for man, dogs and rats have been reviewed from the
literature and are listed in table l of the present investigation.
Plasma volume
Man:
Mean body weight 67 kg; plasma volume 43.5 ml/kg body
weight (79).
Dog:
Mean body weight 31 kg; plasma volume 50 ml/kg body weight
(80).
Rat:
Mean body weight 260g; plasma volume 36.8 ml/kg body
weight (81).
Mathematical analysis of data
According to the diagrammatic Illustration of flgure l, and
based on the above mentioned assumptions the time dependent
change of the intravascular enzyme catalytic activity concentra-
tion (U/l) depends on lymphatic transport (K 4), erythrocyte
derived enzymes (K 6) and the elimination of enzymes from
plasma (K 4).
dC
dt : K - K 4 - C (Eq. 1)
where K is the sum of the lymphatic influx of enzymes and of
the efllux of enzymes from erythrocytes into the plasma, both
of which are constants. K 4 is the elimination constant. Integra-




where C0 is the plasma catalytic activity concentration after a
bolus injection at t = 0. It follows that the steady-state catalytic




Elimination of enzymes from the intravascu-
lar space (K 4)
We should begin by discussing the confusing litera-
ture data for eliminatiori rate constants of enzymes.
These are reviewed in table 1. It is clear that these
values often» difler by more than a factor of 10,
especially in man and to a lesser degree in dogs, Data
from rats are rare.
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It is unlikely that these large differences result from
differences in the basic mechanisms of enzyme elimin-
ation (l, 2, 72, 75, 76, 78, 82, 83). It is much more
likely, rather that they are the result of differences in
methodology.
Most data for man originate from clinical observa-
tions of exponential fits for plasma enzyme levels
after myocardial infarction, liver failures and other
disorders. These clinical studies are based on the
assumption that the particular event had an end point
with respect to the pathological enzyme release and
the increased inflow of enzymes into the intravascular
compartment. Such assumptions are questionable,
however. Enzymes are released for up to 96 h after
myocardial infarction. Therefore, estimation of the
elimination constant from the rate of plasma disap-
pearance 36 or 48 h after the infarct results in large
underestimations (20). In addition, release of enzymes
from secondarily affected organs might change the
typical disappearance pattern of a particular enzyme.
Resupply of the vascular pool from the extravascular
space by delayed lymphatic enzyme transport into
the blood could further slow the disappearance rate.
Results obtained by such studies on apparent half-
life of enzymes in plasma are nevertheless most help-
ful. The knowledge of a true and exact elimination
rate might, in fact, be irrelevant to a physician trying
to make a diagnosis. The knowledge of apparent
disappearence rates obtained from typical uncompli-
cated cases is of considerable value because deviations
therefrom can sometimes signal the development of
complications or other pathological conditions (1).
A more reliable or true elimination rate äs needed
for our quantitative approach can be measured if an
enzyme level can be acutely elevated in the intravascu-
lar compartment and if it can be subsequently ensured
that inflow has definitely ceased. Such a condition
can be achieved only by intravenous injection of
enzymes, which is mostly done in animal studies.
Only a few injection studies have been performed in
humans (30, 49, 50, 53, 84).
These animal studies have led to a better under-
standing of the complex mechanism involved in esti-
mating elimination constants and more elaborate
mathematical procedures have been introduced which
are based upon description of plasma curves äs a sum
of exponentials, each exponential corresponding to a
separate compartment. It has been shown that the
elimination, for instance, of creatine kinase is 3 to
4-times faster in man and animals than previously
reported (4, 20). There remains, however, consider-
able controversial discussion between the few groups
involved with this problem with regard to specific
enzyme elimination constants (4, 20, 61, 70, 85).
J. Clin. Chem. Clin. Biochem, / Vol. 24,1986 / No. l
66 Lindcna et al.: Kinetic of adjustment of enzyme catalytic concentrations in the extracellular space
Some of the assumptions used for the calculations in for malate dehydrogenase in dogs, for aspartate ami-
table 1 are of a dubious nature. It also cannot be notransferase in dogs and rats, and for alanine ami-
decided in every case whether the true or the apparent notransferase in rats exceeds the value of the elimin-
half-life has been determined. As a compromise, ation rate. For both aminotransferases in the rat and
therefore, we have related our data on lymphatic for malate dehydrogenase in dogs, it is obvious that
transport rate and erythrocyte derived enzyme efflux the apparent half-live has been detenpined (60, 77).
under steady-state conditions (K) to both the fastest It follows, that the respective values for K 4 in table
and the slowest elimination constants (K 4). 2 should be higher and the predicted values
KThe uncertainties inherent in the literature data may
explain some of the obvious discrepancies in our
results (tab. 2, tab. 3). The lymphatic transport rate in table 3 should be lower.
Tab. 2. Comparison of eliminating and contributing rate constants to normal catalytic activity in plasma of man, dogs and rats.
K4 is the elimination of enzymes from the intravascular space computed from the normal catalytic activity in plasma
(5), the plasma volume and from mean values or the fastest and slowest half-lives listed in tab. 1.
K 3 is the rate constant of lymphaticaily transported enzymes (2).
K 6 is the erythrocyte-derived enzyme flux (6).


































































































Tab. 3. Comparison of normal catalytic activity concentration (U/l) in plasma of dogs and rats vs. the calculated catalytic activity
concentration.
Normal catalytic activity is taken from the I. communication of this series (5).
— (U/l) is the calculated catalytic activity which is based on values of lymphatic influx of enzymes (2) and of the influx
l̂ V*1! plasm.a from aßeinS erythrocytes (6) divided by elimination constant. See equation 2 under Materials and
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Lymphat ic transport of enzymes (K 3)
The significance of lymphatic transport of enzymes
from tissues into the blood for the level of enzymes
in plasma has been argued by Friedel et al. (86), our
group (87-90) and others.
Our quantitative approach to an explanation of the
exercise-induced changes in catalytic activities in
plasma by the lymphatic influx of enzymes from
the interstitial resting enzyme pool in muscle was
convincing (91). In a previous communication of this
series (2) we presented data on thoracic duct enzyme
transport of dogs, rabbits, rats and mice. These bore
a greater resemblance to physiological conditions
than did previous studies. It was concluded that the
thoracic duct flow and enzyme content should ac-
count for 50—70% of total body lymph flow and
lymph enzyme transport.
For quantitative considerations the lymph enzyme
transport values are therefore extrapolated from 60%
to 100%.
It also became evident from this and the above men-
tioned investigations that neither a release of enzymes
from tissue cells directly into the intravascular space,
(K 8 in fig. 1) nor the exchange rate of enzyme mole-
cules across capillary membranes from the interstitial
to the intravascular space (K 2) are of any significant
importance. The rather complex System of eight rate
constants could therefore be reduced to only four
constants, assuming that the amount of enzymes re-
leased from tissues (K 7) is represented by lymphatic
transport of enzymes (K 3).
The transport rate of enzyme molecules across capil-
lary membranes from the intravascular to the intersti-
tial space (Kl) is not separately considered in our
computations because the K 1-dependent flux recif-
culates via lymphatic transport (K 3); this will be
discussed later. Table 2 relates the rate of enzytne
entry into the plasma, characterized by lymphaticälly
transported enzymes (K 3) and by erythrocyte-
derived enzyme flux (K 6) to the rate of enzyme
elimination from the plasma space (K 4). For man
only the rate constants K 6 and K 4 can be reläted,
Itis demonstrated that lymph enzyme transport from
the tissues is the predominant source of plasma cata-
lytic activity of diagnostically important cell enzymes.
In every case the lymphatic enzyme transport
exceeded the erythrocyte-derived contribution. Some
discrepancies seen for some enzymes, where the lym-
phatic transport rate alone was higher than the elim-
ination rate, have already been attributed above to
methodological difficulties in the estimation of the
true elimination rate constant and may also be due
to different enzyme test conditions in these studies.
The general agreement between data for two different
species (dogs and rats) seems to justify a similar role
for enzyme lymph transport in humans.
The transport rate of enzyme molecules
from the intravascular to the in te r s t i t i a l
space (K 1) and extravascular enzyme dis t r i -
bution space
There is considerable uncertainty about these para-
meters at the present time. Certain misleading con-
cepts and assumptions have been established over the
years because the significance of enzymes in lymph
has been neglected. It is assumed that the process
of exchange of enzyme riiolecules across capillary
membranes from the intravascular to the interstitial
space öccurs by diffusion (10, 12).
Diffusion, however, äs is well known, is proportional
to the differences in concentration between the intra-
vascular and extravascular compartment. The perme-
ability constant for this flux has been estihiated to
be between 0.01 to 0.13 litre per h in man and dogs
(4, 12,20,22,61,92).
However, the fact that most enzymes are found in
much higher catalytic activities in lymph than in
plasma (2) has not been taken into account. Calcula-
tions, based on our data, of the enzyme concentration
of creatine kinase in muscle tissue, lymph and plasma
(2, 5, 89, 90) gave values of 2000 /kg tissue, 50
nmol/i and 20 nmol/1, respectively. Diffusiöfl eertainly
is hot the mechanism of enzyme exchange from the
intravascular to the extravascular space. It is more
likely that enzymes aceompäny pressure-dependent
bulk flow and associatSd ßfötein leakage afcröss the
capillary, especially iti fegions where capillary perme-
ability is high (e. g. liver).
We have proved that enzymes in hepatic lymph orig-
inate preferentially from hepatocytes (2). On the con-
trary, evidence has been presented that hepatic lymph
dörives the bulk of its export proteins such äs albumin
from the plasma (93 — 95), and that the lymph/plasma
concentration ratio of different export proteins was
inversely related to their molecular weight (93). Once
enzymes have reached the circulating blood, they then
should be handled in their passage from the hepatic
sinusoids into liver lymph like any other protein.
Even adenylate kinase, with a molecular weight of
21 000, has a lymph/plasma ratio of 2.4, which far
exceeds the predicted ratio on a molecular weight
dependent basis alone. Liver lymph enzyme transport
accounts for only between about 10 and 20% of total
lymphatic enzyme transport (2). Because the capillary
permeability in other tissues is comparably much
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lower, the significance of exchange of enzymes from
the intravascular to the interstitial space is disre-
garded in our calculation. Its existence, however,
should be kept in mind for the liver.
The flux of enzymes from the intravascular to the
interstitial space should be identical for all enzymes
(except adenylate kinase). There is much experimental
evidence (96, 97) showing that the blood-Iymph bar-
rier does not discriminate in the passage of molecules
if the molecular weight exceeds about 40 000. As the
molecular weights of cell enzymes investigated to date
are about between 70000 and 160000, only small
differences in penneability are to be expected (20,
61). We have shown that adenylate kinase (molecular
weight 20 000) in the thoracic duct, liver and intestinal
lymph is primarily released from tissue cells into the
interstitial space (2).
The extravascular distribution space has been esti-
mated for several enzymes in man, dogs and rats
and controversial results were obtained which not
infrequently differed by a factor of 10 (tab. 4). These
values were obtained by the same groups who contri-
buted the elimination constant data discussed above.
All cited studies were based upon bolus injections of
enzyme preparations or elevation of catalytic activity
after myocardial infarction. In this respect it may be
true that only the plasma distribution compartment
is important if the rate of exchange of enzymes be-
tween the compartments is much slower than the rate
of plasma clearance (61).
Under steady-state conditions, however, a true extra-
vascular distribution space for enzymes is obvious.
The extraceliular fluid volume consists of an intersti-
tial fluid volume (13.0% per kg body weight in man)
and the plasma volume (4.3% per kg body weight)
(98).
An important property imparted to the interstitial
matrix by mucopolysaccharides is the ability of the
entangled gel reticülum to exclude solutes from a
portion of the available intragel water space. The
degree of exclusion is dependent on solute size and
density of the mucopolysaccharide meshwork. A nor-
mal interstitium is capable of excluding albuinin from
50% of its structure; -globulin is excluded from 70%
of the matrix volume (99, 100).
It can be assumed, therefore, that the diagnostically
important enzymes with molecular weights äs linän-
tioned above are distributed extravascularly in a vol-
ume that is almost twice the plasma volume.
Release of enzymes from bood cells (K 6)
To test the hypothesis that circulating erythrocytes
make a significant contribution to the normal cata-
lytic activity in plasma, it was assumed in the forego-
ing publication (6) äs a working hypothesis, that the
measured loss of catalytic activity in ageing erythro-
cytes is equivalent to the amount of the enzymes
released in catalytically active form into plasma.
Tab. 4. Extravascular distribution space of enzymes expressed äs percentage of intravascular (plasma) distribution space. The
values indicated are means and/or ranges from the cited literature.
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In dogs and rats the contribution from ageing ery-
throcytes accounts for 20—45% for lactate dehydro-
genase and malate dehydrogenase, 10 — 20% for
adenylate kinase and phosphohexose isomerase,
5 — 10% for aspartate aminotransferase and aldolase
and only about 1% for creatine kinase. These rela-
tions roughly reflect the scaled intracellular erythro-
cyte catalytic activity pattern of these enzymes (101,
102). In man a similar order of magnitude can be
calculated when one relates the rate constant from
erythrocytes to that of the elimination constant.
These observations make an erythrocyte-derived con-
tribution to the basal plasma catalytic activity quite
plausible. Convincing experimental evidence for such
a contribution is lacking to date. There are, however,
several further arguments which could support this
hypothesis. Diederichs et al. (103) recently developed
a theory of enzyme release which äs a general rule
may also hold true for erythrocytes. The following
findings support this theory: In "old" erythrocytes
ATP levels have been found to be greatly decreased,
äs the result of impaired glucose utilisation in the
Embden-Meyerhofpzthway (104-108). Low K+ and
high Na+ and Ca2+ concentrations are also found in
these cells (107, 109 — 113). In ageing erythrocytes
decreased levels of total ATP-ase and Na+/K+ ATP-
ase have been observed (107, 114, 115). Ca2+ ions
leak into the cytoplasmic coinpartment and, at low
ATP concentration, induce an outward directed bleb-
bing and vesiculation of parts of the cell membrane
by contractions of the erythrocyte cytoskeleton.
Senescent erythrocytes have decreased cholesterol
and phospholipid contents and decreased membrane
surface (107). Release of spectrin-free vesicles from
human erythrocytes during ATP depletion has been
observed (116). This leads to a reduced mean corpu-
scular volume and an increased density (104, 107,
110, 117-119).
The actions of Ca2+ also may involve activation by
Ca2+ of a K+ channel in the membrane (120) and
subsequent shrinking.
It must, however, be restated that there is no decisive
proof whatsoever that the decline of catalytic activi-
ties in ageing erythrocytes is due to a loss by release.
The reported contribution of enzyme efflux from in
vivo ageing erythrocytes into the plasma in relation
to lymphatic transport of enzymes is represented by
maximal values.
Kinetic, isozymic and structural modifications of dis-
tinct enzymes (6) also point towards inactivation with
age.
For enzymes of diagnostic importance the erythro-
cyte-derived enzymes, efflux is of no account.
The contribution of blood cells other than erythro-
cytes to the basal plasma catalytic activity is largely
unknown. The small volume fraction of polymor-
phonuclear cells, e. g., in relation to red blood cells, is
nearly totally-compensated by their high intracellular
catalytic activity (101, 102).
Several particulate and soluble Stimuli induce not
only these cells but also monocytes to release lysoso-
mal enzymes with minimal associated leakage of cyto-
plasmic enzymes (120 — 124). In contrast to the well
documented correlation between erythrocyte density,
age, and diminishing enzyme content, the causes and
importance of platelet heterogeneity remain contro-
versial (125, 126).
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